Fairvalue-Calculator Fairvalue-Calculator
EN DE

Assicurazioni Generali S.p.A (ARZGY) Fair Value & Analysis

Financial Services · US · Market cap $73.0B

Price$24.04
Fair Value$19.38
Upside-19.4%
Quality94/100
Evidence: High Range $12.78 – $24.72

Analysis

Assicurazioni Generali S.p.A (ARZGY) currently trades at $24.04, while our model-based Fair Value estimate is $19.38 — implying the stock looks roughly 19.4% overvalued today. We read business quality at 94/100 (high quality), in the Financial Services sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Assicurazioni Generali S.p.A. provides various insurance solutions under the Generali brand in the Americas, Italy, rest of Europe, Africa, the Middle East, Asia, and the Oceania. The company operates through Life, Property & Casualty, and Asset & Wealth Management segments. It offers savings, individual and family protection, and unit linked products, as well as motor third-party liability, home, property and casualty, accident, health, and commercial and industrial risks insurance products; and insurance plans for multinational companies. It also provides equity and fixed-income funds, and alternative products. The company was formerly known as Assicurazioni Generali Austro-Italiche and changed its name to Assicurazioni Generali S.p.A. in 1848. Assicurazioni Generali S.p.A. was founded in 1831 and is headquartered in Trieste, Italy.

Open the full interactive analysis →

Similar stocks

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.